Evogene Ltd.EVGNNASDAQ

Overview Intelligence Charts News Fundamentals

Loading chart...

Prev Close

0.82

Day Range

0.81-0.89

Volume

36K

Market Cap

P/E

-0.7

52-Week Range1-2

0.81Current 0.812.42

Alerts

Quick Start

1. Track EVGN with alerts 2. Compare EVGN vs SPY 3. Open key fundamentals chart

Want to monitor EVGN?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor EVGN

Key Statistics

Volume Distribution

About

Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd.

Sector

Manufacturing

Industry

Pesticide and Other Agricultural Chemical Manufacturing

www.evogene.com →

News

Snowflake Inc. (SNOW) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

seekingalpha.com

Coursera, Inc. (COUR) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

seekingalpha.com

Bragar Eagel & Squire, P.C. Urges CoreWeave, Inc. (NASDAQ:CRWV) Stockholders with Large Losses to Contact the Firm Before March 13th

globenewswire.com

VERSABANK REPORTS STRONG FIRST QUARTER RESULTS: ACCELERATED U.S. GROWTH DRIVES 31% YEAR-OVER-YEAR INCREASE IN REVENUE, 36% YEAR-OVER-YEAR GROWTH IN NET INCOME, 49% YEAR-OVER-YEAR GROWTH IN ADJUSTED NET INCOME

prnewswire.com

ROSEN, NATIONAL TRIAL COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX

newsfilecorp.com

SNOW Investors Have Opportunity to Lead Snowflake Inc. Securities Fraud Lawsuit

prnewswire.com

NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Lawsuit

prnewswire.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Quick Start

Key Statistics

Volume Distribution

About

News

Snowflake Inc. (SNOW) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Coursera, Inc. (COUR) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Bragar Eagel & Squire, P.C. Urges CoreWeave, Inc. (NASDAQ:CRWV) Stockholders with Large Losses to Contact the Firm Before March 13th

Tidewater: Strong Quarter, Accretive Acquisition - Buy

NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript

Rio Tinto and WA Government partner to expand Dampier Seawater Desalination Plant

Oil rises over $1 as Iran crisis disrupts Middle East supply

Pegasystems Inc. (PEGA) Presents at Emerging Technology Summit Transcript

Halozyme Therapeutics, Inc. (HALO) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Prediction: Nvidia (NVDA) Will Be Worth More Than Alphabet, Apple, Amazon, Tesla, Meta, and Microsoft Combined by 2030

Semtech Corporation (SMTC) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

DraftKings Is Using Its Sports-Betting Playbook to Win Prediction Markets Race

Cinemark Holdings, Inc. (CNK) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Meta Creates New AI Unit to Accelerate Model Development

HII's Ingalls Shipbuilding Authenticates Keel of Philadelphia (LPD 32)

VERSABANK REPORTS STRONG FIRST QUARTER RESULTS: ACCELERATED U.S. GROWTH DRIVES 31% YEAR-OVER-YEAR INCREASE IN REVENUE, 36% YEAR-OVER-YEAR GROWTH IN NET INCOME, 49% YEAR-OVER-YEAR GROWTH IN ADJUSTED NET INCOME

ROSEN, NATIONAL TRIAL COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX

SNOW Investors Have Opportunity to Lead Snowflake Inc. Securities Fraud Lawsuit

NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Lawsuit

Explore More

Key Statistics